Status |
Commissioning |
Source |
Superconducting (SC) Wiggler |
Energy Range |
20 – 100 keV |
Wavelength |
0.6
– 0.1 Å |
Resolution Δ E / E @ E |
M1 CT:10-3
M2 CT:10-3
M3 DEI:10-5
M4 KES:10-3 |
Photon Brightness ( γ /s/0.1%BW) @ 100 mA |
3 x 10¹² ph (s * mr² * 0.1%bW * mA) @ 20 keV |
Beam Size (Horizontal x Vertical) |
220 mm x 11 mm @ 55 m |
Description: The BioMedical Imaging and Therapy (BMIT) beamline is designed for the purpose of imaging biological tissue and conducting radiation therapy research. The BMIT facility will address the interest of scientists and clinicians in the diagnosis and treatment of cancer (breast tumours and paediatric oncology), circulatory and respiratory disease (heart disease and asthma) neurological and behavioural disease (brain and spinal cord injuries, epilepsy), reproductive dysfunction (infertility, menopause, and contraceptives), musculo-skeletal disease and kinesiology (arthritis, athletic injuries), and dental conditions (temporomandibular disease).
Endstation(s):
- Therapy
a) Custom positioning system. Max. load capacity 136 kg
- Imaging
a) Custom positioning system. Max. load capacity 450 kg.
Techniques:
- Imaging – conventional absorption imaging, DEI / MIR, CT, K-edge Subtraction (KES)
- Therapy – Microbeam Radiation Therapy, CT Therapy
Optics:
Technical beamline one-pager (PDF)
|
Left to right: David Cooper, Jeffrey To, Denise Miller, Dean Chapman (above), Adam Webb, Stephen Hanson; In front: Tomasz Wysokinski, George Belev
|
